Mathieu Bourdenx - Publications

Affiliations: 
Albert Einstein College of Medicine, New York, New York, United States 
Area:
Neuroscience, Neurodegeneration, Protein aggregation, Proteostasis, Aging, Lysosomes, Prion

40 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Madrigal-Matute J, de Bruijn J, van Kuijk K, Riascos-Bernal DF, Diaz A, Tasset I, Martín-Segura A, Gijbels MJJ, Sander B, Kaushik S, Biessen EAL, Tiano S, Bourdenx M, Krause GJ, McCracken I, et al. Protective role of chaperone-mediated autophagy against atherosclerosis. Proceedings of the National Academy of Sciences of the United States of America. 119: e2121133119. PMID 35363568 DOI: 10.1073/pnas.2121133119  0.704
2022 Teil M, Dovero S, Bourdenx M, Arotcarena ML, Camus S, Porras G, Thiolat ML, Trigo-Damas I, Perier C, Estrada C, Garcia-Carrillo N, Morari M, Meissner WG, Herrero MT, Vila M, et al. Brain injections of glial cytoplasmic inclusions induce a multiple system atrophy-like pathology. Brain : a Journal of Neurology. PMID 35285474 DOI: 10.1093/brain/awab374  0.828
2022 Fleming A, Bourdenx M, Fujimaki M, Karabiyik C, Krause GJ, Lopez A, Martín-Segura A, Puri C, Scrivo A, Skidmore J, Son SM, Stamatakou E, Wrobel L, Zhu Y, Cuervo AM, et al. The different autophagy degradation pathways and neurodegeneration. Neuron. PMID 35134347 DOI: 10.1016/j.neuron.2022.01.017  0.54
2022 Kirchner P, Bourdenx M, Madrigal-Matute J, Tiano S, Diaz A, Bartholdy BA, Will B, Cuervo AM. Correction: Proteome-wide analysis of chaperone-mediated autophagy targeting motifs. Plos Biology. 20: e3001550. PMID 35120120 DOI: 10.1371/journal.pbio.3001550  0.419
2021 Juste YR, Kaushik S, Bourdenx M, Aflakpui R, Bandyopadhyay S, Garcia F, Diaz A, Lindenau K, Tu V, Krause GJ, Jafari M, Singh R, Muñoz J, Macian F, Cuervo AM. Reciprocal regulation of chaperone-mediated autophagy and the circadian clock. Nature Cell Biology. PMID 34876687 DOI: 10.1038/s41556-021-00800-z  0.67
2021 Bourdenx M, Gavathiotis E, Cuervo AM. Chaperone-mediated autophagy: a gatekeeper of neuronal proteostasis. Autophagy. 1-3. PMID 34110247 DOI: 10.1080/15548627.2021.1935007  0.556
2021 Bourdenx M, Martín-Segura A, Scrivo A, Rodriguez-Navarro JA, Kaushik S, Tasset I, Diaz A, Storm NJ, Xin Q, Juste YR, Stevenson E, Luengo E, Clement CC, Choi SJ, Krogan NJ, et al. Chaperone-mediated autophagy prevents collapse of the neuronal metastable proteome. Cell. PMID 33891876 DOI: 10.1016/j.cell.2021.03.048  0.746
2021 Caballero B, Bourdenx M, Luengo E, Diaz A, Sohn PD, Chen X, Wang C, Juste YR, Wegmann S, Patel B, Young ZT, Kuo SY, Rodriguez-Navarro JA, Shao H, Lopez MG, et al. Acetylated tau inhibits chaperone-mediated autophagy and promotes tau pathology propagation in mice. Nature Communications. 12: 2238. PMID 33854069 DOI: 10.1038/s41467-021-22501-9  0.538
2021 Klionsky DJ, Abdel-Aziz AK, Abdelfatah S, Abdellatif M, Abdoli A, Abel S, Abeliovich H, Abildgaard MH, Abudu YP, Acevedo-Arozena A, Adamopoulos IE, Adeli K, Adolph TE, Adornetto A, Aflaki E, ... ... Bourdenx M, et al. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition). Autophagy. 1-382. PMID 33634751 DOI: 10.1080/15548627.2020.1797280  0.762
2020 Bourdenx M, Nioche A, Dovero S, Arotcarena ML, Camus S, Porras G, Thiolat ML, Rougier NP, Prigent A, Aubert P, Bohic S, Sandt C, Laferrière F, Doudnikoff E, Kruse N, et al. Identification of distinct pathological signatures induced by patient-derived α-synuclein structures in nonhuman primates. Science Advances. 6: eaaz9165. PMID 32426502 DOI: 10.1126/Sciadv.Aaz9165  0.801
2020 Arotcarena ML, Dovero S, Prigent A, Bourdenx M, Camus S, Porras G, Thiolat ML, Tasselli M, Aubert P, Kruse N, Mollenhauer B, Damas IT, Estrada C, Garcia-Carrillo N, Vaikath NN, et al. Bidirectional gut-to-brain and brain-to-gut propagation of synucleinopathy in non-human primates. Brain : a Journal of Neurology. PMID 32380543 DOI: 10.1093/Brain/Awaa096  0.814
2019 Arotcarena ML, Bourdenx M, Dutheil N, Thiolat ML, Doudnikoff E, Dovero S, Ballabio A, Fernagut PO, Meissner WG, Bezard E, Dehay B. Transcription factor EB overexpression prevents neurodegeneration in experimental synucleinopathies. Jci Insight. 4. PMID 31434803 DOI: 10.1172/Jci.Insight.129719  0.823
2019 Kirchner P, Bourdenx M, Madrigal-Matute J, Tiano S, Diaz A, Bartholdy BA, Will B, Cuervo AM. Proteome-wide analysis of chaperone-mediated autophagy targeting motifs. Plos Biology. 17: e3000301. PMID 31150375 DOI: 10.1371/Journal.Pbio.3000301  0.527
2018 Geier EG, Bourdenx M, Storm NJ, Cochran JN, Sirkis DW, Hwang JH, Bonham LW, Ramos EM, Diaz A, Van Berlo V, Dokuru D, Nana AL, Karydas A, Balestra ME, Huang Y, et al. Rare variants in the neuronal ceroid lipofuscinosis gene MFSD8 are candidate risk factors for frontotemporal dementia. Acta Neuropathologica. PMID 30382371 DOI: 10.1007/S00401-018-1925-9  0.56
2018 Scrivo A, Bourdenx M, Pampliega O, Cuervo AM. Selective autophagy as a potential therapeutic target for neurodegenerative disorders. The Lancet. Neurology. 17: 802-815. PMID 30129476 DOI: 10.1016/S1474-4422(18)30238-2  0.616
2018 Chansel-Debordeaux L, Bourdenx M, Dutheil N, Dovero S, Canron MH, Jimenez C, Bezard E, Dehay B. Systemic gene delivery by single-dose intracardiac administration of scAAV2/9 and scAAV2/rh10 variants in newborn rats. Human Gene Therapy Methods. PMID 30064266 DOI: 10.1089/Hgtb.2017.192.R3  0.769
2017 Chansel-Debordeaux L, Bourdenx M, Dovero S, Grouthier V, Dutheil N, Espana A, Groc L, Jimenez C, Bezard E, Dehay B. In utero delivery of rAAV2/9 induces neuronal expression of the transgene in the brain: towards new models of Parkinson's disease. Gene Therapy. 24: 801-809. PMID 28853717 DOI: 10.1038/Gt.2017.84  0.808
2017 Bastide MF, Glangetas C, Doudnikoff E, Li Q, Bourdenx M, Fernagut PO, Dumont ÉC, Georges F, Bézard E. Involvement of the bed nucleus of the stria terminalis in L-Dopa induced dyskinesia. Scientific Reports. 7: 2348. PMID 28539659 DOI: 10.1038/S41598-017-02572-9  0.609
2017 Cavaliere F, Cerf L, Dehay B, Ramos-Gonzalez P, De Giorgi F, Bourdenx M, Bessede A, Obeso JA, Matute C, Ichas F, Bezard E. In vitro α-synuclein neurotoxicity and spreading among neurons and astrocytes using Lewy body extracts from Parkinson disease brains. Neurobiology of Disease. 103: 101-112. PMID 28411117 DOI: 10.1016/J.Nbd.2017.04.011  0.813
2017 Bourdenx M, Dovero S, Thiolat ML, Bezard E, Dehay B. Lack of spontaneous age-related brain pathology in Octodon degus: a reappraisal of the model. Scientific Reports. 7: 45831. PMID 28374864 DOI: 10.1038/Srep45831  0.806
2017 Bourdenx M, Dehay B. [Autophagy and brain: the case of neurodegenerative diseases]. Medecine Sciences : M/S. 33: 268-274. PMID 28367813 DOI: 10.1051/Medsci/20173303013  0.776
2017 Soria FN, Pampliega O, Bourdenx M, Meissner WG, Bezard E, Dehay B. Exosomes, an Unmasked Culprit in Neurodegenerative Diseases. Frontiers in Neuroscience. 11: 26. PMID 28197068 DOI: 10.3389/Fnins.2017.00026  0.795
2016 Bourdenx M, Dehay B. What lysosomes actually tell us about Parkinson's disease? Ageing Research Reviews. 32: 140-149. PMID 26947123 DOI: 10.1016/J.Arr.2016.02.008  0.809
2016 Dehay B, Decressac M, Bourdenx M, Guadagnino I, Fernagut PO, Tamburrino A, Bassil F, Meissner WG, Bezard E. Targeting α-synuclein: Therapeutic options. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 26926119 DOI: 10.1002/Mds.26568  0.82
2016 Bourdenx M, Daniel J, Genin E, Soria FN, Blanchard-Desce M, Bezard E, Dehay B. Nanoparticles restore lysosomal acidification defects: Implication for Parkinson and other lysosomal-related diseases. Autophagy. 0. PMID 26761717 DOI: 10.1080/15548627.2015.1136769  0.815
2015 Bourdenx M, Dehay B, Bezard' E. Experimental modelling of -synuclein aggregation and spreading in synucleinopathies. Bulletin De L'Academie Nationale De Medecine. 199: 797-808. PMID 29901880  0.788
2015 Bourdenx M, Dovero S, De Deurwaerdère P, Li Q, Bezard E. Early Prenatal Exposure to MPTP Does Not Affect Nigrostrial Neurons in Macaque Monkey. Synapse (New York, N.Y.). PMID 26584009 DOI: 10.1002/Syn.21876  0.779
2015 Bastide MF, Meissner WG, Picconi B, Fasano S, Fernagut PO, Feyder M, Francardo V, Alcacer C, Ding Y, Brambilla R, Fisone G, Jon Stoessl A, Bourdenx M, Engeln M, Navailles S, et al. Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease. Progress in Neurobiology. PMID 26209473 DOI: 10.1016/J.Pneurobio.2015.07.002  0.787
2015 Bourdenx M, Koulakiotis NS, Sanoudou D, Bezard E, Dehay B, Tsarbopoulos A. Protein aggregation and neurodegeneration in prototypical neurodegenerative diseases: Examples of amyloidopathies, tauopathies and synucleinopathies. Progress in Neurobiology. PMID 26209472 DOI: 10.1016/J.Pneurobio.2015.07.003  0.821
2015 Bourdenx M, Dovero S, Engeln M, Bido S, Bastide MF, Dutheil N, Vollenweider I, Baud L, Piron C, Grouthier V, Boraud T, Porras G, Li Q, Baekelandt V, Scheller D, et al. Lack of additive role of ageing in nigrostriatal neurodegeneration triggered by α-synuclein overexpression. Acta Neuropathologica Communications. 3: 46. PMID 26205255 DOI: 10.1186/S40478-015-0222-2  0.791
2015 Dehay B, Bourdenx M, Gorry P, Przedborski S, Vila M, Hunot S, Singleton A, Olanow CW, Merchant KM, Bezard E, Petsko GA, Meissner WG. Targeting α-synuclein for treatment of Parkinson's disease: mechanistic and therapeutic considerations. The Lancet. Neurology. PMID 26050140 DOI: 10.1016/S1474-4422(15)00006-X  0.83
2015 Barroso-Chinea P, Thiolat ML, Bido S, Martinez A, Doudnikoff E, Baufreton J, Bourdenx M, Bloch B, Bezard E, Martin-Negrier ML. D1 dopamine receptor stimulation impairs striatal proteasome activity in Parkinsonism through 26S proteasome disassembly. Neurobiology of Disease. 78: 77-87. PMID 25766677 DOI: 10.1016/J.Nbd.2015.02.024  0.569
2015 Bourdenx M, Dehay B, Bezard E. Modélisation expérimentale de l’agrégation et de la propagation de l’α-synucléine dans les synucléinopathies Bulletin De L'AcadéMie Nationale De MéDecine. 199: 797-808. DOI: 10.1016/S0001-4079(19)30882-9  0.738
2014 Bourdenx M, Dehay B, Bezard E. Down-regulating α-synuclein for treating synucleopathies. Movement Disorders : Official Journal of the Movement Disorder Society. 29: 1463-5. PMID 25214445 DOI: 10.1002/Mds.26028  0.775
2014 Bourdenx M, Bezard E, Dehay B. Lysosomes and α-synuclein form a dangerous duet leading to neuronal cell death. Frontiers in Neuroanatomy. 8: 83. PMID 25177278 DOI: 10.3389/Fnana.2014.00083  0.835
2014 Engeln M, Bastide MF, Toulmé E, Dehay B, Bourdenx M, Doudnikoff E, Li Q, Gross CE, Boué-Grabot E, Pisani A, Bezard E, Fernagut PO. Selective Inactivation of Striatal FosB/ΔFosB-Expressing Neurons Alleviates L-Dopa-Induced Dyskinesia. Biological Psychiatry. PMID 25146322 DOI: 10.1016/J.Biopsych.2014.07.007  0.77
2014 Bourdenx M, Dutheil N, Bezard E, Dehay B. Systemic gene delivery to the central nervous system using Adeno-associated virus. Frontiers in Molecular Neuroscience. 7: 50. PMID 24917785 DOI: 10.3389/Fnmol.2014.00050  0.777
2014 Bourdenx M, Nilsson A, Wadensten H, Fälth M, Li Q, Crossman AR, Andrén PE, Bezard E. Abnormal structure-specific peptide transmission and processing in a primate model of Parkinson's disease and l-DOPA-induced dyskinesia. Neurobiology of Disease. 62: 307-12. PMID 24148855 DOI: 10.1016/J.Nbd.2013.10.016  0.661
2013 Bourdenx M. Allograft of stem cell-derived dopaminergic neurons for Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 28: 736. PMID 23712582 DOI: 10.1002/Mds.25497  0.447
2013 Bourdenx M. Phosphorylation of α-synuclein at Ser120 accelerates neurodegeneration. Movement Disorders : Official Journal of the Movement Disorder Society. 28: 441. PMID 23568844 DOI: 10.1002/Mds.25413  0.351
Show low-probability matches.